Global Menopausal Hormone Therapy Supply, Demand and Key Producers, 2023-2029

Global Menopausal Hormone Therapy Supply, Demand and Key Producers, 2023-2029

The global Menopausal Hormone Therapy market size is expected to reach $ 35970 million by 2029, rising at a market growth of 5.8% CAGR during the forecast period (2023-2029).

The menopausal hormone therapy (MHT) market is expected to grow significantly in the coming years, driven by a number of factors, including:

Rising awareness of the benefits of menopausal hormone therapy: There is a growing awareness of the benefits of menopausal hormone therapy, such as relief of menopausal symptoms, reduced risk of osteoporosis, and improved cardiovascular health. This is also driving the demand for menopausal hormone therapy.

Changing social norms: Social norms are changing around menopause, and women are becoming more open to discussing their symptoms and seeking treatment. This is also driving the demand for menopausal hormone therapy.

The North American region is expected to be the largest market for menopausal hormone therapy, followed by Europe and the Asia Pacific region. The growth of the market in the North American region is being driven by the high prevalence of menopause and the easy availability of menopausal hormone therapy products.

Overall, the menopausal hormone therapy market is expected to grow significantly in the coming years, driven by increasing population of menopausal women, rising awareness of the benefits of menopausal hormone therapy, and changing social norms.

Menopausal hormone therapy (MHT) is a treatment that uses hormones to relieve the symptoms of menopause. Menopause is a natural process that occurs when a woman's ovaries stop producing estrogen and progesterone. This can cause a variety of symptoms, including hot flashes, night sweats, vaginal dryness, mood swings, and difficulty sleeping.

This report studies the global Menopausal Hormone Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Menopausal Hormone Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Menopausal Hormone Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Menopausal Hormone Therapy total market, 2018-2029, (USD Million)

Global Menopausal Hormone Therapy total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Menopausal Hormone Therapy total market, key domestic companies and share, (USD Million)

Global Menopausal Hormone Therapy revenue by player and market share 2018-2023, (USD Million)

Global Menopausal Hormone Therapy total market by Type, CAGR, 2018-2029, (USD Million)

Global Menopausal Hormone Therapy total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Menopausal Hormone Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Menopausal Hormone Therapy market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Menopausal Hormone Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Menopausal Hormone Therapy Market, Segmentation by Type
Estrogen
Progesterone

Global Menopausal Hormone Therapy Market, Segmentation by Application
Hospital
Clinic
Others

Companies Profiled:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD

Key Questions Answered

1. How big is the global Menopausal Hormone Therapy market?

2. What is the demand of the global Menopausal Hormone Therapy market?

3. What is the year over year growth of the global Menopausal Hormone Therapy market?

4. What is the total value of the global Menopausal Hormone Therapy market?

5. Who are the major players in the global Menopausal Hormone Therapy market?